A detailed history of Strategic Blueprint, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Strategic Blueprint, LLC holds 46,227 shares of PFE stock, worth $1.24 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
46,227
Previous 52,389 11.76%
Holding current value
$1.24 Million
Previous $1.47 Million 8.74%
% of portfolio
0.09%
Previous 0.11%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$27.7 - $31.39 $170,687 - $193,425
-6,162 Reduced 11.76%
46,227 $1.34 Million
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $43,320 - $50,764
1,715 Added 3.38%
52,389 $1.47 Million
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $384,854 - $441,936
14,865 Added 41.51%
50,674 $1.41 Million
Q4 2023

Jan 25, 2024

SELL
$26.13 - $33.94 $249,698 - $324,330
-9,556 Reduced 21.06%
35,809 $1.03 Million
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $33,469 - $39,122
1,043 Added 2.35%
45,365 $1.5 Million
Q2 2023

Oct 18, 2023

BUY
$36.12 - $41.79 $61,945 - $71,669
1,715 Added 4.03%
44,322 $1.63 Million
Q1 2023

Apr 28, 2023

SELL
$39.39 - $51.28 $1.77 Million - $2.31 Million
-45,042 Reduced 51.39%
42,607 $1.74 Million
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $2.12 Million - $2.77 Million
50,855 Added 138.22%
87,649 $0
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $108,874 - $132,908
2,488 Added 7.25%
36,794 $1.61 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $79,938 - $94,782
1,718 Added 5.27%
34,306 $1.8 Million
Q1 2022

Aug 12, 2022

BUY
$45.75 - $56.69 $77,088 - $95,522
1,685 Added 5.45%
32,588 $1.69 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $115,819 - $171,683
2,803 Added 9.98%
30,903 $1.82 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $48,473 - $62,268
1,235 Added 4.6%
28,100 $1.21 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $63,776 - $72,247
1,776 Added 7.08%
26,865 $1.05 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $27,729 - $31,273
828 Added 3.41%
25,089 $909,000
Q4 2020

Jan 26, 2021

BUY
$33.47 - $42.56 $189,038 - $240,378
5,648 Added 30.34%
24,261 $893,000
Q3 2020

Oct 27, 2020

BUY
$31.75 - $37.25 $256,698 - $301,166
8,085 Added 76.8%
18,613 $683,000
Q2 2020

Jul 20, 2020

BUY
$30.12 - $36.54 $3,795 - $4,604
126 Added 1.21%
10,528 $344,000
Q1 2020

Apr 20, 2020

BUY
$27.03 - $38.62 $324 - $463
12 Added 0.12%
10,402 $340,000
Q4 2019

Jan 10, 2020

BUY
$32.92 - $37.36 $269,055 - $305,343
8,173 Added 368.65%
10,390 $407,000
Q3 2019

Oct 16, 2019

SELL
$32.49 - $42.13 $1.13 Million - $1.46 Million
-34,770 Reduced 94.01%
2,217 $80,000
Q2 2019

Jul 09, 2019

BUY
$36.98 - $41.52 $83,685 - $93,959
2,263 Added 6.52%
36,987 $1.6 Million
Q1 2019

Apr 10, 2019

BUY
$37.5 - $41.2 $117,412 - $128,997
3,131 Added 9.91%
34,724 $1.48 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $1.22 Million - $1.39 Million
31,593 New
31,593 $1.38 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.